US EditionSylogist is still a buy, Ventum says
Summary by Cantech Letter
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Sylogist is still a buy, Ventum says
Amr Ezzat, an analyst with Ventum Capital Markets, says Sylogist’s (Sylogist Stock Quote, Chart, News, Analysts, Financials TSXV:SYZ) recent US$10.6-million statewide contract win in Texas is a strong endorsement of the company’s Victim Services Suite and its overall strategy. This marks Sylogist’s third VSS deal in the U.S. this year and, according to Ezzat, “represents […] Source
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
